Tom V, Jose A, Mallick S, Sasidharan A, Pawar R, Somayaji Y
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 40063239
DOI: 10.1007/s00210-025-03985-4.
Zhou Z, Zhang Y, Zhou Y, Gu J, Li J, Shao J
PeerJ. 2025; 13:e18911.
PMID: 39995998
PMC: 11849515.
DOI: 10.7717/peerj.18911.
Wu H, Zhang W, Chang J, Wu J, Zhang X, Jia F
Sci Rep. 2025; 15(1):6173.
PMID: 39979377
PMC: 11842742.
DOI: 10.1038/s41598-024-85035-2.
He R, Qi P, Shu L, Ding Y, Zeng P, Wen G
J Exp Clin Cancer Res. 2025; 44(1):44.
PMID: 39915884
PMC: 11804008.
DOI: 10.1186/s13046-025-03313-x.
Alberti-Valls M, Olave S, Olomi A, Macia A, Eritja N
Cancers (Basel). 2024; 16(23).
PMID: 39682106
PMC: 11640124.
DOI: 10.3390/cancers16233918.
Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment.
Wang J, He Y, Hu F, Hu C, Sun Y, Yang K
Int J Mol Sci. 2024; 25(22).
PMID: 39596288
PMC: 11594648.
DOI: 10.3390/ijms252212223.
Extracellular Matrix as a Target in Melanoma Therapy: From Hypothesis to Clinical Trials.
Mayasin Y, Osinnikova M, Kharisova C, Kitaeva K, Filin I, Gorodilova A
Cells. 2024; 13(22).
PMID: 39594665
PMC: 11592585.
DOI: 10.3390/cells13221917.
The complex role of regulatory cells in breast cancer: implication for immunopathogenesis and immunotherapy.
Guo R, Wang P
Breast Cancer. 2024; 32(2):227-241.
PMID: 39589625
DOI: 10.1007/s12282-024-01654-7.
SHR-1806, a robust OX40 agonist to promote T cell-mediated antitumor immunity.
Zhang J, Zhou L, Sun X, Lin Y, Yuan J, Yang C
Cancer Biol Ther. 2024; 25(1):2426305.
PMID: 39543823
PMC: 11572088.
DOI: 10.1080/15384047.2024.2426305.
Regulatory T cells in immune checkpoint blockade antitumor therapy.
Zhang A, Fan T, Liu Y, Yu G, Li C, Jiang Z
Mol Cancer. 2024; 23(1):251.
PMID: 39516941
PMC: 11545879.
DOI: 10.1186/s12943-024-02156-y.
Amphiregulin promotes activated regulatory T cell-suppressive function via the AREG/EGFR pathway in laryngeal squamous cell carcinoma.
Li H, Fang R, Ma R, Long Y, He R, Lyu H
Head Face Med. 2024; 20(1):62.
PMID: 39456084
PMC: 11515249.
DOI: 10.1186/s13005-024-00466-6.
Beyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression.
Sabit H, Arneth B, Abdel-Ghany S, Madyan E, Ghaleb A, Selvaraj P
Cells. 2024; 13(19).
PMID: 39404428
PMC: 11475877.
DOI: 10.3390/cells13191666.
Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies.
Ciepla J, Smolarczyk R
Clin Exp Med. 2024; 24(1):235.
PMID: 39361163
PMC: 11449960.
DOI: 10.1007/s10238-024-01501-1.
Elimination of Human Papillomavirus 16-Positive Tumors by a Mucosal rAd5 Therapeutic Vaccination in a Pre-Clinical Murine Study.
Braun M, Moore A, Lindbloom J, Hodgson K, Dora E, Tucker S
Vaccines (Basel). 2024; 12(9).
PMID: 39339987
PMC: 11435741.
DOI: 10.3390/vaccines12090955.
Antisense targeting of FOXP3+ Tregs to boost anti-tumor immunity.
Akimova T, Wang L, Bartosh Z, Christensen L, Eruslanov E, Singhal S
Front Immunol. 2024; 15:1426657.
PMID: 39234236
PMC: 11371716.
DOI: 10.3389/fimmu.2024.1426657.
Advances in immunotoxin engineering: precision therapeutic strategies in modern oncology.
Oghalaie A, Hosseini M, Hosseininejad-Chafi M, Eftekhari Z, Behdani M, Kazemi-Lomedasht F
Med Oncol. 2024; 41(10):239.
PMID: 39230639
DOI: 10.1007/s12032-024-02478-3.
Regulatory T cells and immune escape in HCC: understanding the tumor microenvironment and advancing CAR-T cell therapy.
Du G, Dou C, Sun P, Wang S, Liu J, Ma L
Front Immunol. 2024; 15:1431211.
PMID: 39136031
PMC: 11317284.
DOI: 10.3389/fimmu.2024.1431211.
Spatial cell interplay networks of regulatory T cells predict recurrence in patients with operable non-small cell lung cancer.
Cai S, Yang G, Hu M, Li C, Yang L, Zhang W
Cancer Immunol Immunother. 2024; 73(10):189.
PMID: 39093404
PMC: 11297009.
DOI: 10.1007/s00262-024-03762-x.
Microbiome and pancreatic cancer: time to think about chemotherapy.
De Castilhos J, Tillmanns K, Blessing J, Larano A, Borisov V, Stein-Thoeringer C
Gut Microbes. 2024; 16(1):2374596.
PMID: 39024520
PMC: 11259062.
DOI: 10.1080/19490976.2024.2374596.
invariant Natural Killer T cell therapy as a novel therapeutic approach in hematological malignancies.
Boonchalermvichian C, Yan H, Gupta B, Rubin A, Baker J, Negrin R
Front Transplant. 2024; 3:1353803.
PMID: 38993780
PMC: 11235242.
DOI: 10.3389/frtra.2024.1353803.